Bates & Company, Inc.
|
Loan & Distribution Specialist AimPoint Pension
|
AimPoint Pension
|
Defined Benefit Combo Cash Balance Compliance Consultant Loren D. Stark Company (LDSCO)
|
Compass
|
Regional Vice President of Sales The Retirement Plan Company
|
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
FDA's Approval of New Alzheimer's Drug Has Multibillion Dollar Implications for Medicare
Henry J. Kaiser Family Foundation June 29, 2021 "In 2017, nearly 2 million Medicare beneficiaries used one or more of the currently-available Alzheimer's treatments covered under Part D ... If just one-quarter of these beneficiaries are prescribed Aduhelm, or 500,000 beneficiaries, and Medicare pays 103% of $56,000 in the near term, total spending for Aduhelm in one year alone would be nearly $29 billion ... [T]otal Medicare spending for all Part B drugs was $37 billion in 2019." |
Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |